Colgate-Palmolive Company $CL Stock Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. boosted its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 18.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,651,979 shares of the company’s stock after acquiring an additional 251,887 shares during the quarter. Russell Investments Group Ltd.’s holdings in Colgate-Palmolive were worth $141,843,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Virginia Estate & Retirement Planning Advisors Inc. increased its holdings in shares of Colgate-Palmolive by 1,409.1% in the 3rd quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock worth $28,000 after purchasing an additional 310 shares in the last quarter. Parvin Asset Management LLC bought a new position in shares of Colgate-Palmolive during the second quarter valued at $32,000. Park Place Capital Corp boosted its position in shares of Colgate-Palmolive by 55.5% during the second quarter. Park Place Capital Corp now owns 356 shares of the company’s stock valued at $33,000 after buying an additional 127 shares during the last quarter. Cherry Tree Wealth Management LLC boosted its position in shares of Colgate-Palmolive by 7,840.0% during the second quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company’s stock valued at $36,000 after buying an additional 392 shares during the last quarter. Finally, Montgomery Financial Services LLC purchased a new stake in shares of Colgate-Palmolive during the second quarter valued at $36,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL opened at $99.62 on Monday. The firm has a market capitalization of $79.19 billion, a P/E ratio of 39.07, a PEG ratio of 4.51 and a beta of 0.31. The company has a debt-to-equity ratio of 11.23, a current ratio of 0.96 and a quick ratio of 0.63. Colgate-Palmolive Company has a one year low of $75.96 and a one year high of $101.18. The business has a fifty day moving average of $90.94 and a 200 day moving average of $90.29.

Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. During the same quarter in the prior year, the company earned $0.91 earnings per share. Colgate-Palmolive’s revenue was up 4.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.92 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th were paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Tuesday, October 20th. Colgate-Palmolive’s payout ratio is currently 83.14%.

Insider Buying and Selling at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 19,938 shares of the stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $98.74, for a total value of $1,968,678.12. Following the transaction, the chief operating officer owned 9,111 shares in the company, valued at $899,620.14. This represents a 68.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Gregory Malcolm sold 4,100 shares of the firm’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $97.97, for a total transaction of $401,677.00. Following the completion of the transaction, the executive vice president directly owned 10,061 shares in the company, valued at approximately $985,676.17. The trade was a 28.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 77,414 shares of company stock worth $7,613,786 over the last 90 days. 0.43% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on CL. Weiss Ratings downgraded Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Evercore upped their target price on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. Deutsche Bank reaffirmed a “buy” rating and set a $101.00 price target (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $90.00 to $95.00 and gave the stock an “equal weight” rating in a research note on Monday, November 2nd. Finally, Raymond James Financial boosted their price objective on shares of Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a report on Monday, August 3rd. Thirteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $101.22.

Read Our Latest Analysis on CL

Top Colgate-Palmolive Stories

Investors following CL have been watching these stories:

  • Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $3.91 from $3.85, close to the $3.92 consensus, and nudged its FY2027 and FY2028 forecasts higher to $4.06 and $4.38, respectively. These revisions suggest modest confidence in longer-term earnings growth. Zacks Research Has Bullish Forecast for CL FY2026 Earnings
  • Neutral Sentiment: The analyst revisions were not uniformly positive: Zacks also lowered several quarterly estimates, including Q1 and Q2 FY2027 and Q1 and Q2 FY2028, while increasing others. The overall picture is therefore mixed rather than a broad-based upgrade. Zacks Research forecast coverage
  • Negative Sentiment: A Colgate-Palmolive executive vice president sold $401,677 worth of company shares. Insider sales can weigh on sentiment, although a single transaction does not necessarily indicate a change in the company’s outlook. Insider Selling: Colgate-Palmolive EVP Sells Stock

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.